You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

300 Results
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Funding:
New Drug Funding Program
    Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Aggressive Histology Lymphoma
ODB - General Benefit
    dexamethasone
New Drug Funding Program
    Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Aggressive Histology Lymphoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
dexamethasone,
riTUXimab,
gemcitabine,
CARBOplatin,
riTUXimab (subcut)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jan 2024
Drug
Other Name(s): Gleevec®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Dec 2024
Drug
Other Name(s): Xeloda®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jul 2024
Drug
Other Name(s): Anandron® ()
Quick Link(s):
Drug Monograph, Patient Info Sheet
Sep 2018
Drug
Other Name(s): Temodal®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jun 2021
Drug
Other Name(s): Femara®
Quick Link(s):
Drug Monograph, Patient Info Sheet
May 2022
Drug
Other Name(s): Zoladex® (AstraZeneca) , Zoladex® LA (AstraZeneca)
Quick Link(s):
Drug Monograph, Patient Info Sheet
Mar 2016
Drug
Other Name(s): Busulfex® , Myleran®
Quick Link(s):
Drug Monograph
Jun 2019
Drug
Other Name(s): Megace® (multiple brands available)
Quick Link(s):
Drug Monograph, Patient Info Sheet
Aug 2016
Drug
Other Name(s): Arimidex®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Oct 2024
Drug
Other Name(s): Nolvadex®-D
Quick Link(s):
Drug Monograph, Patient Info Sheet
May 2022
Drug
Other Name(s): Casodex® (multiple brands available)
Quick Link(s):
Drug Monograph, Patient Info Sheet
Apr 2024

Pages